Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil effects on BP and endothelial function in hypertension
NCT00317421Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sildenafil in hypertension (HTN) (2 arms), sponsored by University of Edinburgh. Primary endpoints: Change in blood pressure at 2 weeks, Change in flow-mediated dilatation at 2 weeks and 2 more. Started Mar 2004; status: completed.
02
Drugs
sildenafil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00317421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317421.